Our study highlights the role of EV MALAT1-miR-129-5p-HMGB1 in the modulation of the inflammatory response in microglial cells, which holds great promise to serve as a therapeutic target for glioma treatments. The gene discussed is HMGB1; the disease is central nervous system cancer.